AMC Entertainment Holdings, Inc. AMC

Key data

The business

AMC runs the largest cinema circuit in the US plus a big European one, and it makes money three ways, where the mix matters more than the total. Admissions, $863 million last quarter, is the top line but the thin one, because studios take roughly half of every ticket back as film-exhibition cost ($440 million against that $863 million). Food and beverage, $576 million, is where the profit lives: popcorn and soda carry gross margins above 80%, and getting each guest to spend more at the counter is the one lever management actually controls. The third slice, other theatre ($157 million), is screen advertising and the loyalty program. The moat is thin, the best seats in the best locations and a scaled loyalty base, not a structural lock. Attendance is the master variable, and attendance is set by Hollywood's release calendar, which AMC does not control.

The numbers

Two things are true at once: the theaters are working again, and the balance sheet is not. The last five quarters, with Q4 2025 derived from the full-year filing (it foots to the annual):

Q2 2026 was the strongest quarter in years, revenue up 14% on the year and operating income of $238 million against $92.6 million. The Street's adjusted line landed at +$0.14 versus $0.03 expected, a clean beat, while GAAP stayed a small loss because interest swallowed the operating gain. The pattern is unmistakable: even quarters carrying the spring and summer slate print operating profit, the shoulder quarters bleed. This business tracks the release calendar to the week.

Revenue has clawed back to roughly its 2019 level in nominal dollars, and the operating loss shrank to just $17 million in 2025 from $930 million in 2021. The recovery in the theaters is real. What did not recover is the per-share claim: the loss line never closed and the share count multiplied.

Here is the whole thing. Enterprise value is about $9.3 billion, of which the stock is $2.37 billion; the other roughly $7 billion is debt and leases. Consensus sees revenue reaching $5.5 billion in 2026 on a heavy slate and $5.75 billion in 2027, yet still forecasts per-share losses both years (−$0.23, −$0.06). You are not buying a compounder. You are buying a levered claim on whether recovering theater cash can service and eventually refinance a $4 billion debt stack before the 2029-2030 walls without another wave of dilution. What this memo believes that the tape does not: the operating turn is genuine, but the equity is worth something only if the refinancing goes on debt terms, and the single print that settles it is sustained positive free cash flow across a full four quarters, which has not happened, trailing free cash flow to equity was a bare $41 million and capital spending still ran above operating cash.

Management

Adam Aron, CEO since 2016, is the operator who kept AMC alive through 2020-2021 by selling stock to a retail army, the move that saved the company and permanently diluted it. His scorecard is exactly that decision: survival bought with shares. The one insider action in the last year is his own open-market purchase of $344,000 in May 2026 (plan status not disclosed), the only insider transaction on file, a modest vote with real money. Pay has drawn repeated shareholder criticism, and buybacks are beside the point here, the capital story runs the other way, toward issuance. Watch what he does with equity, not what he says.

How it fails or surprises you

Refinancing forces more dilution. AMC owes about $4 billion, carries negative equity, and current maturities jumped to $149 million from $20 million. If the 2029-2030 walls get refinanced with equity or equity-linked paper, per-share value takes another leg down no matter how full the theaters are. First tell: any new at-the-market equity program or exchange offer in the 8-K flow.

The slate delivers and the math flips (right tail). The 2026-2027 release calendar is one of the densest in years. If it drives attendance the way the spring quarter hints, cash earnings could reach a level that lets AMC refinance on debt terms, not equity, and the survival discount closes quickly. The market is pricing endurance, not recovery. First tell: two straight quarters of positive free cash flow.

The operating turn was slate timing, not structure. The fact this read explains least well: operating income leapt to $238 million in Q2, yet trailing free cash flow is barely positive and Q1 burned $129 million of operating cash. If the strength is just hits bunching into even quarters, the annual figure reverts and nothing deleverages. First tell: whether full-year 2026 operating cash flow turns clearly positive against 2025's $120 million outflow.

Closing thoughts

The refinancing wall around 2029-2030 is what settles it: whether AMC rolls that $4 billion on debt terms using earned cash, or whether management prints more shares to stay alive and the per-share claim gets crushed again. The film slate between now and then determines which outcome. The distribution is barbell-shaped: a fat left tail where dilution or weak attendance grinds the equity toward zero on a balance sheet already carrying negative net worth, and a real right tail where a strong two-year slate drives enough operating cash for a debt-based refinancing and the survival discount closes. The left tail is fatter because the debt maturity is certain and the box office is not, and what is at risk is most of the equity if the refinancing goes wrong, against a double or more if the slate holds. Those odds are judgment, not arithmetic.

The bet is still that Americans keep filling AMC's seats and buying its popcorn, and that the theaters throw off enough cash to handle the debt without drowning shareholders in new stock. It breaks the day management funds the next maturity with equity instead of earnings. The pair to watch: full-year operating cash flow against the $4 billion debt balance. If the cash cannot cover it, the seats being full will not matter.